Global Biodefense Market Professional Survey Report 2016
- QYR607703
- 111 Pages
- June 2016
- Healthcare
Segment regions including (the separated region report can also be offered)
North America
Europe
Japan
China
Southeast Asia
India
The players list (Partly, Players you are interested in can also be added)
Xoma Corporation
PharmAthene
Emergent Biosolutions
Dynavax Technologies Inc.
SIGA Technologies
Elusys Therapeutics
Ichor Medical Systems Inc.
DynPort Vaccine Company LLC
Cleveland BioLabs, Inc.
Bavarian Nordic
Achaogen
Nanotherapeutics, Inc.
Alnylam Pharmaceuticals
With 13 top producers.
Data including (both global and regions): Market Size (both volume - K Units and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Unit, Cost, Gross margin etc.
More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
1 Industry Overview of Biodefense
1.1 Definition and Specifications of Biodefense
1.1.1 Definition of Biodefense
1.1.2 Specifications of Biodefense
1.2 Classification of Biodefense
1.3 Applications of Biodefense
1.4 Industry Chain Structure of Biodefense
1.5 Industry Overview and Major Regions Status of Biodefense
1.5.1 Industry Overview of Biodefense
1.5.2 Global Major Regions Status of Biodefense
1.6 Industry Policy Analysis of Biodefense
1.7 Industry News Analysis of Biodefense
2 Manufacturing Cost Structure Analysis of Biodefense
2.1 Raw Material Suppliers and Price Analysis of Biodefense
2.2 Equipment Suppliers and Price Analysis of Biodefense
2.3 Labor Cost Analysis of Biodefense
2.4 Other Costs Analysis of Biodefense
2.5 Manufacturing Cost Structure Analysis of Biodefense
2.6 Manufacturing Process Analysis of Biodefense
3 Technical Data and Manufacturing Plants Analysis of Biodefense
3.1 Capacity and Commercial Production Date of Global Biodefense Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Biodefense Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Biodefense Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Biodefense Major Manufacturers in 2015
4 Global Biodefense Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2.1 2011-2015 Global Biodefense Capacity and Growth Rate Analysis
4.2.2 2015 Biodefense Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2015 Global Biodefense Sales and Growth Rate Analysis
4.3.2 2015 Biodefense Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2015 Global Biodefense Sales Price
4.4.2 2015 Biodefense Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
4.5.1 2011-2015 Global Biodefense Gross Margin
4.5.2 2015 Biodefense Gross Margin Analysis (Company Segment)
5 Biodefense Regional Market Analysis
5.1 North America Biodefense Market Analysis
5.1.1 North America Biodefense Market Overview
5.1.2 North America 2011-2016E Biodefense Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2011-2016E Biodefense Sales Price Analysis
5.1.4 North America 2015 Biodefense Market Share Analysis
5.2 Europe Biodefense Market Analysis
5.2.1 Europe Biodefense Market Overview
5.2.2 Europe 2011-2016E Biodefense Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2011-2016E Biodefense Sales Price Analysis
5.2.4 Europe 2015 Biodefense Market Share Analysis
5.3 Japan Biodefense Market Analysis
5.3.1 Japan Biodefense Market Overview
5.3.2 Japan 2011-2016E Biodefense Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Japan 2011-2016E Biodefense Sales Price Analysis
5.3.4 Japan 2015 Biodefense Market Share Analysis
5.4 China Biodefense Market Analysis
5.4.1 China Biodefense Market Overview
5.4.2 China 2011-2016E Biodefense Local Supply, Import, Export, Local Consumption Analysis
5.4.3 China 2011-2016E Biodefense Sales Price Analysis
5.4.4 China 2015 Biodefense Market Share Analysis
5.5 Southeast Asia Biodefense Market Analysis
5.5.1 Southeast Asia Biodefense Market Overview
5.5.2 Southeast Asia 2011-2016E Biodefense Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia 2011-2016E Biodefense Sales Price Analysis
5.5.4 Southeast Asia 2015 Biodefense Market Share Analysis
5.6 India Biodefense Market Analysis
5.6.1 India Biodefense Market Overview
5.6.2 India 2011-2016E Biodefense Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2011-2016E Biodefense Sales Price Analysis
5.6.4 India 2015 Biodefense Market Share Analysis
6 Global 2011-2016E Biodefense Segment Market Analysis (by Type)
6.1 Global 2011-2016E Biodefense Sales by Type
6.2 Different Types Biodefense Product Interview Price Analysis
6.3 Different Types Biodefense Product Driving Factors Analysis
7 Global 2011-2016E Biodefense Segment Market Analysis (by Application)
7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
8 Major Manufacturers Analysis of Biodefense
8.1 Xoma Corporation
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 Xoma Corporation 2015 Biodefense Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Xoma Corporation 2015 Biodefense Business Region Distribution Analysis
8.2 PharmAthene
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 PharmAthene 2015 Biodefense Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 PharmAthene 2015 Biodefense Business Region Distribution Analysis
8.3 Emergent Biosolutions
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Emergent Biosolutions 2015 Biodefense Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Emergent Biosolutions 2015 Biodefense Business Region Distribution Analysis
8.4 Dynavax Technologies Inc.
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Dynavax Technologies Inc. 2015 Biodefense Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Dynavax Technologies Inc. 2015 Biodefense Business Region Distribution Analysis
8.5 SIGA Technologies
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 SIGA Technologies 2015 Biodefense Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 SIGA Technologies 2015 Biodefense Business Region Distribution Analysis
8.6 Elusys Therapeutics
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 Elusys Therapeutics 2015 Biodefense Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Elusys Therapeutics 2015 Biodefense Business Region Distribution Analysis
8.7 Ichor Medical Systems Inc.
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.3 Ichor Medical Systems Inc. 2015 Biodefense Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Ichor Medical Systems Inc. 2015 Biodefense Business Region Distribution Analysis
8.8 DynPort Vaccine Company LLC
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.3 DynPort Vaccine Company LLC 2015 Biodefense Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 DynPort Vaccine Company LLC 2015 Biodefense Business Region Distribution Analysis
8.9 Cleveland BioLabs, Inc.
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.3 Cleveland BioLabs, Inc. 2015 Biodefense Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Cleveland BioLabs, Inc. 2015 Biodefense Business Region Distribution Analysis
8.10 Bavarian Nordic
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.3 Bavarian Nordic 2015 Biodefense Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Bavarian Nordic 2015 Biodefense Business Region Distribution Analysis
8.11 Achaogen
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.3 Achaogen 2015 Biodefense Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Achaogen 2015 Biodefense Business Region Distribution Analysis
8.12 Nanotherapeutics, Inc.
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 Nanotherapeutics, Inc. 2015 Biodefense Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Nanotherapeutics, Inc. 2015 Biodefense Business Region Distribution Analysis
8.13 Alnylam Pharmaceuticals
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.3 Alnylam Pharmaceuticals 2015 Biodefense Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 Alnylam Pharmaceuticals 2015 Biodefense Business Region Distribution Analysis
9 Development Trend of Analysis of Market
9.1 Global Market Trend Analysis
9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Sales Price Forecast
9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
9.2.1 North America 2016-2021 Biodefense Consumption Forecast
9.2.2 Europe 2016-2021 Biodefense Consumption Forecast
9.2.3 Japan 2016-2021 Biodefense Consumption Forecast
9.2.4 China 2016-2021 Biodefense Consumption Forecast
9.2.5 Southeast Asia 2016-2021 Biodefense Consumption Forecast
9.2.6 India 2016-2021 Biodefense Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)
10 Biodefense Marketing Model Analysis
10.1 Biodefense Regional Marketing Model Analysis
10.2 Biodefense International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Biodefense by Regions
10.4 Biodefense Supply Chain Analysis
11 Consumers Analysis of Biodefense
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 New Project Investment Feasibility Analysis of Biodefense
12.1 New Project SWOT Analysis of Biodefense
12.2 New Project Investment Feasibility Analysis of Biodefense
13 Conclusion of the Global Biodefense Market Professional Survey Report 2016
N/A
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
